EUVIMEDEUVIMED entdecken
Crossref

Timing of RhD ‐positive red blood cell administration is associated with D‐alloimmunization in injured patients

Mark H Yazer iD, Philip C Spinella, Jason Sperry, Darrell J Triulzi, Christine Leeper iD

Transfusion · 2023

DOI: 10.1111/trf.17330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von Mark H Yazer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Isoantibodies, Anemia, Hemolytic, Autoimmune. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The D‐alloimmunization rate in trauma patients does not appear to depend on the number of RhD‐positive units transfused. The effect of the timing and pattern of RhD‐positive transfusions has not been evaluated.

Methods

RhD‐negative trauma patients who were transfused with RhD‐positive red blood cells (RBC) or low titer group O whole blood (collectively called RBCs) on at least two separate calendar days and who had antibody detection tests performed at least 14 days after the second RhD‐positive RBC transfusion without receiving RhIg were included in the analysis. Patients whose anti‐D was detected within 14 days of the index RhD‐positive RBC transfusion were excluded. Patient demographics and the dates of RhD‐positive RBC transfusions and results of antibody detection tests performed after the index transfusion were collected on eligible patients.

Results

There were 44/61 (72.1%) patients in whom anti‐D was not detected (non‐alloimmunized) and 17/61 (27.9%) in whom anti‐D was detected (alloimmunized). The patients had similar demographics with trends towards higher median admission heart rates and lower median admission Glasgow Coma Scale values in the alloimmunized group. Both groups received statistically identical median quantities of RhD‐positive RBCs (non‐alloimmunized 5 vs. alloimmunized 4 units, p = .53), however, the alloimmunized group received all their RhD‐positive RBCs over a significantly shorter period of time compared to the non‐alloimmunized (median 4 vs. 15 days, respectively, p = .01).

Conclusion

Receipt of all RhD‐positive RBCs over a shorter period of time was associated with higher D‐alloimmunization rates. These results need to be confirmed in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoantibodiesAnemia, Hemolytic, AutoimmuneHumansErythrocytesErythrocyte TransfusionBlood Transfusion

Stichwörter der Autor:innen

RhDalloimmunizationantibodylow titer group O whole bloodred blood celltransfusiontrauma

Substanzen

Isoantibodies

Autor:innen und Institutionen

  • Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Vitalant, Pittsburgh, Pennsylvania, USA.
  • Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Mark H Yazer, Christine Leeper

Zitieren

APA

Yazer, M. H., Spinella, P. C., Sperry, J., Triulzi, D. J., & Leeper, C. (2023). Timing of RhD ‐positive red blood cell administration is associated with D‐alloimmunization in injured patients. Transfusion. https://doi.org/10.1111/trf.17330

Vancouver

Yazer MH, Spinella PC, Sperry J, Triulzi DJ, Leeper C. Timing of RhD ‐positive red blood cell administration is associated with D‐alloimmunization in injured patients. Transfusion. 2023. doi:10.1111/trf.17330

BibTeX
@article{Yazer2023,
  author = {Yazer, Mark H and Spinella, Philip C and Sperry, Jason and Triulzi, Darrell J and Leeper, Christine},
  title = {Timing of RhD ‐positive red blood cell administration is associated with D‐alloimmunization in injured patients},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17330}
}
Kostenlos starten →